Balaxi Pharmaceuticals Ltd. - Research Center
Group () BSE data
Add to watchlist
| Results | |
| Statement | |
| More |
Ratio
|
Ratios
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Per share ratios | |||||
| Adjusted EPS (Rs) | 3.35 | 15.93 | 14.67 | 15.13 | 6.50 |
| Adjusted cash EPS (Rs) | 3.82 | 16.44 | 14.92 | 15.22 | 6.50 |
| Reported EPS (Rs) | 3.35 | 15.93 | 14.67 | 15.13 | 6.50 |
| Reported cash EPS (Rs) | 3.82 | 16.44 | 14.92 | 15.22 | 6.50 |
| Dividend per share | - | - | - | - | - |
| Operating profit per share (Rs) | 4.80 | 16.52 | 17.26 | 18.89 | 6.46 |
| Book value (excl rev res) per share EPS (Rs) | 108.07 | 80.35 | 57.91 | 43.25 | 28.11 |
| Book value (incl rev res) per share EPS (Rs) | 108.07 | 80.35 | 57.91 | 43.25 | 28.11 |
| Net operating income per share EPS (Rs) | 64.41 | 106.21 | 101.29 | 86.87 | 45.63 |
| Free reserves per share EPS (Rs) | - | - | - | - | - |
| Profitability ratios | |||||
| Operating margin (%) | 7.45 | 15.55 | 17.04 | 21.74 | 14.16 |
| Gross profit margin (%) | 6.73 | 15.07 | 16.79 | 21.64 | 14.14 |
| Net profit margin (%) | 5.20 | 15.00 | 14.48 | 17.42 | 14.23 |
| Adjusted cash margin (%) | 5.73 | 14.58 | 14.33 | 17.16 | 13.42 |
| Adjusted return on net worth (%) | 3.09 | 19.82 | 25.32 | 34.99 | 23.10 |
| Reported return on net worth (%) | 3.09 | 19.82 | 25.32 | 34.99 | 23.10 |
| Return on long term funds (%) | 6.04 | 28.00 | 34.11 | 47.65 | 32.95 |
| Leverage ratios | |||||
| Long term debt / Equity | - | - | - | - | - |
| Total debt/equity | 0.11 | 0.13 | 0.03 | 0.08 | - |
| Owners fund as % of total source | 89.40 | 88.38 | 96.77 | 92.50 | 100.00 |
| Fixed assets turnover ratio | 0.58 | 1.33 | 1.90 | 2.32 | 2.89 |
| Liquidity ratios | |||||
| Current ratio | 6.63 | 3.70 | 2.70 | 2.20 | 3.84 |
| Current ratio (inc. st loans) | 2.67 | 2.06 | 2.48 | 1.90 | 3.84 |
| Quick ratio | 6.59 | 3.65 | 2.70 | 2.20 | 3.76 |
| Inventory turnover ratio | 0.53 | 1.17 | 1.69 | 1.86 | 1.62 |
| Payout ratios | |||||
| Dividend payout ratio (net profit) | - | 3.08 | - | - | - |
| Dividend payout ratio (cash profit) | - | 2.98 | - | - | - |
| Earning retention ratio | 100.00 | 96.92 | 100.00 | 100.00 | 100.00 |
| Cash earnings retention ratio | 100.00 | 97.02 | 100.00 | 100.00 | 100.00 |
| Coverage ratios | |||||
| Adjusted cash flow time total debt | 3.35 | 0.64 | 0.12 | 0.23 | - |
| Financial charges coverage ratio | 4.95 | 51.03 | 326.96 | 1,579.95 | - |
| Fin. charges cov.ratio (post tax) | 3.70 | 37.47 | 244.75 | 1,162.90 | - |
| Component ratios | |||||
| Material cost component (% earnings) | 80.47 | 75.91 | 75.93 | 72.89 | 73.58 |
| Selling cost Component | 0.19 | 0.19 | 0.39 | 0.08 | 0.22 |
| Exports as percent of total sales | 92.32 | - | - | - | - |
| Import comp. in raw mat. consumed | - | - | - | - | - |
| Long term assets / total Assets | 0.18 | 0.23 | 0.27 | 0.29 | 0.01 |
| Bonus component in equity capital (%) | 5.96 | 6.38 | 6.50 | 6.50 | 6.50 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis